ask="N/A"
ask_size="N/A"
average_daily_volume="170469"
bid="N/A"
bid_size="N/A"
book_value="1.383"
change="-0.025"
change_from_200_day_moving_average="-0.550"
change_from_50_day_moving_average="0.190"
change_from_52_week_high="-2.725"
change_From_52_week_low="1.005"
change_in_percent="-0.442%"
close="5.625"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.606"
ebitda="-55.83M"
eps_estimate_current_year="-1.250"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-1.090"
ex_dividend_date="N/A"
float_shares="42788000"
high="5.650"
high_52_weeks="8.350"
last_trade_date="2/16/2017"
last_trade_price="5.625"
last_trade_size="4447"
last_trade_time="4:00pm"
low="5.600"
low_52_weeks="4.620"
market_capitalization="325.91M"
moving_average_200_day="6.175"
moving_average_50_day="5.435"
name="Sorrento Therapeutics
Inc."
notes="N/A"
one_year_target_price="25.000"
open="5.650"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-8.909%"
percent_change_from_50_day_moving_average="+3.501%"
percent_change_from_52_week_high="-32.635%"
percent_change_from_52_week_low="+21.753%"
previous_close="5.650"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.085"
price_per_sales="59.846"
revenue="5.47M"
shares_outstanding="57939000"
short_ratio="28.150"
stock_exchange="NCM"
symbol="SRNE"
volume="82829"
weeks_range_52="4.620 - 8.350"
